Clinical Pathways in Neuro-ophthalmology : An ... - E-Lib FK UWKS

More documents

Recommendations

Info

116 Clinical Pathways in Neuro-Ophthalmology, second edition McHugh NJ, James IE, Plant GT. (1990). Anticardiolipin and antineutrophil antibodies in giant cell arteritis. J Rheumatol 17:916–922. McLean CA, Gonzales MF, Dowling JP. (1993). Systemic giant cell arteritis and cerebellar infarction. Stroke 24:899–902. Melberg NS, Grand MG, Diekert JP, et al. (1995). Cotton-wool spots and the early diagnosis of giant cell arteritis. Ophthalmology 102:1611–1614. Miller A, Green M. (1983). Simple rule for calculating normal erythrocyte sedimentation rate. Br Med J 286:266. Miller NR. (1991). Walsh and Hoyt’s Clinical Neuro-ophthalmology. 4th ed. Baltimore, Williams & Wilkins, pp. 2601–2627. Miller NR. (2000). Giant cell arteritis. J Neuro-ophthalmol 20:219–221. Mitnich HJ, Tunick PA, Rotterdam H, et al. (1990). Antemortem diagnosis of giant cell aortitis. J Rheumatol 17:708. Mizen TR. (1991). Giant cell arteritis: diagnostic and therapeutic considerations. Ophthalmol Clin North Am 4:547–556. Myles AB, Perera T, Ridley MG. (1992). Prevention of blindness in giant cell arteritis by corticosteroid treatment. Br J Rheumatol 31:103–105. Nadeau SE. (1988). Temporal arteritis: a decision-analytical approach to temporal artery biopsy. Acta Neurol Scand 78:90–100. Neish PR, Sergent JS. (1991). Giant cell arteritis: a case with unusual neurologic manifestations and a normal sedimentation rate. Arch Intern Med 151:378–380. Nesher G, Sonnenblick M, Friedlander Y. (1994). Analysis of steroid related complications and mortality in temporal arteritis: a 15 year survey of 43 patients. J Rheumatol 21:1283. Ninet JP, Bachet P, Dumontet CM, et al. (1990). Subclavian and axillary involvement in temporal arteritis and polymyalgia rheumatica. Am J Med 88:13. Nishino H, DeRemee RA, Rubino FA, Parisi JE. (1993). Wegener’s granulomatosis associated with vasculitis of the temporal artery: report of five cases. Mayo Clin Proc 68:115–121. Nordborg E, Bengtsson BA. (1990). Epidemiology of biopsy-proven giant cell arteritis (GCA). J Intern Med 227:233. Olopade CO, Sekosan M, Schraufnagel DE. (1997). Giant cell arteritis manifesting as chronic cough and fever of unknown origin. Mayo Clin Proc 72:1048–1050. Orgull S, Gass A, Flammer J. (1994). Optic disc cupping in arteritic anterior ischemic optic neuropathy. Ophthalmologica 208:336–338. Orrell RW, Johnson MH. (1993). Plasma viscosity and the diagnosis of giant cell arteritis. Br J Clin Pract 47:71–72. Pache M, Kaiser HJ, Haufschild T, et al. (2002). Increased endothelin-1 plasma levels in giant cell arteritis: a report on four patients. Am J Ophthalmol 133:160–162. Pascual-Sedano B, Roig C. (1998). Horner’s syndrome due to giant cell arteritis. Neuro-ophthalmology 20:75–77. Pedro-Botet J, Coll J, Lopez MJ, Grau JM. (1996). Pericardial effusion and giant cell arteritis (letter). Br J Rheumatol 35:194–195. Petzold A, Plant GT, Scaravilli F. (2002). Rapidly developing intimal fibrosis mimicking giant cell arteritis. Br J Ophthalmol 86:114–115. Phelan MJ, Kok K, Burrow C, Thompson RN. (1993). Small bowel infarction in association with giant cell arteritis. Br J Rheumatol 32:63–65. Pless M, Rizzo JF III, Lamkin JC, Lessell S. (2000). Concordance of bilateral temporal artery biopsy in giant cell arteritis. J Neuro-ophthalmol 20:216–218. Ponge T, Barrier JH, Grolleau JY, et al. (1988). The efficacy of selective unilateral temporal artery biopsy versus bilateral biopsies for diagnosis of giant cell arteritis. J Rheumatol 15:997. Postel EA, Pollock SC. (1993). Recovery of vision in a 47-year-old man with fulminant giant cell arteritis. J Clin Neuro-ophthalmol 13:262–270. Pountain G, Calvin J, Hazleman BL. (1994). Alpha 1-antichymotrypsin, C-reactive protein and erythrocyte sedimentation rate in polymyalgia rheumatica and giant cell arteritis. Br J Rheumatol 33:550–554. Pountain G, Hazleman B. (1995). ABC of rheumatology. Polymyalgia rheumatica and giant cell arteritis. Br Med J 310:1057–1059. Quillen DA, Cantore WA, Schwartz SR, Brod RD, Saddani JW. (1993). Choroidal nonperfusion in giant cell arteritis. Am J Ophthalmol 116:171–175. Radda TM, Pehamberger H, Smolen J, Menzel J. (1981). Ocular manifestation of temporal arteritis: immunological studies. Arch Ophthalmol 99:487–488. Rajesh CV, Cole M. (2000). Panuveitis as a presenting feature of giant cell arteritis. Br J Ophthalmol 84:340. Rauser M, Rismondo V. (1995). Ischemic optic neuropathy during corticosteroid therapy for giant cell arteritis (letter). Arch Ophthalmol 113:707–708. Reich KA, Giansiracusa DF, Strongwater SL. (1990). Neurologic manifestations of giant cell arteritis. Am J Med 89:67–72.
Arteritic Anterior Ischemic Optic Neuropathy and Giant Cell Arteritis 117 Richardson MP, Lever AM, Fink AM, Dixon AK, Hazleman BL. (1996). Survival after aortic dissection in giant cell arteritis (letter). Ann Rheum Dis 55:332–333. Rischmueller M, Davies RP, Smith MD. (1996). Three year follow-up of a case of giant cell arteritis presenting with a chronic cough and upper limb ischaemic symptoms. Br J Rheumatol 35:800–802. Rivest D, Brunet D, Desbiens R, Bouchard JP. (1995). C-5 radiculopathy as a manifestation of giant cell arteritis. Neurology 45:1222–1224. Robb-Nicholson C, Chang RW, Anderson S, et al. (1988). Diagnostic value of history and examination in giant cell arteritis: a clinical pathological study of 81 temporal artery biopsies. J Rheumatol 15:1793. Ronchetto F. (1992). Transient monocular blindness in a patient with giant-cell arteritis. Pathogenetic and therapeutic considerations (letter). Recent Prog Med 83:241–242. Rousseau P. (1994). Giant cell arteritis. Arch Fam Med 3:628–632. Rudd JC. (1998). Ischemic scalp necrosis preceding loss of visual acuity in giant cell arteritis. Arch Ophthalmol 116:1690–1691. Ruiz-Masera JJ, Alamillos-Granados FJ, Dean-Ferrer A, et al. (1995). Submandibular swelling as the first manifestation of giant cell arteritis. Report of a case. J Craniomaxillofac Surg 23:119–121. Russell RW. (1996). Giant cell arteritis—a clinical review. Curr Med Drugs 7:3–8. Sadda SR, Nee M, Miller NR, et al. (2001). Clinical spectrum of posterior ischemic optic neuropathy. Am J Ophthalmol 132:743–750. Salvarani C, Gabriel SE, O’Fallon WM, Hunder GG. (1995). The incidence of giant cell arteritis in Olmsted County, Minnesota: apparent fluctuations in cyclic pattern. Ann Intern Med 123:192–194. Salvarani C, Hunder GG. (2001). Giant cell arteritis with low erythrocyte sedimentation rate: frequency of occurrence in a population-based study. Arthritis Rheum 45:140–145. Salvarani C, Macchioni P, Zizzi F, et al. (1991). Epidemiologic and immunogenic aspects of polymyalgia rheumatica and giant cell arteritis in northern Italy. Arthritis Rheum 34:351–356. Savino PJ. (2000). Giant cell arteritis. J Neuro-ophthalmol 20:221. Schauble B, Wijman CAC, Koleini B, Babikian VL. (2000). Ophthalmic artery microembolism in giant cell arteritis. J Neuro-ophthalmol 20:273–275. Schaufelberger C. (1998). No additive effect of cyclosporin A compared with glucocorticoid treatment alone in giant cell arteritis: results of an open, controlled, randomized study. Br J Rheumatol 37:464–465. Schmidt D, Loffler KU. (1994). Temporal arteritis. Comparison of histological and clinical findings. Acta Ophthalmol 72:319–325. Schwartz NG, Beck RW, Savino PJ, et al. (1995). Pain in anterior ischemic optic neuropathy. J Neuro-ophthalmol 15:9–10. Segato T, Piermarocchi S, Midena E. (1990). The role of fluorescein angiography in the interpretation of optic nerve head diseases. Metab Pediatr Syst Ophthalmol 13:111–114. Sehgal M, Swanson JW, DeRemee RA, Cobly TV. (1995). Neurologic manifestations of Churg-Strauss syndrome. Mayo Clin Proc 70:337–341. Shanahan EM, Hutchinson M, Hanley SD, Bresnihan B. (1999). Giant cell arteritis presenting as lateral medullary syndrome. Rheumatology 38:188–189. Sheehan MM, Keohane C, Twomey C. (1993). Fatal vertebral giant cell arteritis. J Clin Pathol 46:1129–1131. Siatkowski RM, Gass JDM, Glaser JS, Smith JL, Schatz NJ, Schiffman J. (1993). Fluorescein angiography in the diagnosis of giant cell arteritis. Am J Ophthalmol 115:57–63. Slamovits TL, Matzkin SC, Burde RM, Sachs R. (1992). IV steroids for central retinal artery occlusion in giant cell arteritis. (letter). Ophthalmology 99:1482–1484. Slavin ML, Barnondes MJ. (1994). Visual loss caused by choroidal ischemia preceding anterior ischemic optic neuropathy in giant cell arteritis. Am J Ophthalmol 117:81–86. Sonnenblick M, Nesher G, Friedlander Y, Rubinow A. (1994). Giant cell arteritis in Jerusalem: a 12-year epidemiologic study. Br J Rheumatol 33:938–941. Sox HC, Liang MH. (1986). The erythrocyte sedimentation rate: guidelines for rational use. Ann Intern Med 104:515–523. Stauton H, Safford F, Leader M, O’Riordain D. (2000). Deterioration of giant cell arteritis with corticosteroid therapy. Arch Neurol 57:581–584. Stebbing J, Buetens O, Hellmann D, Stone J. (1999). Secondary amyloidosis associated with giant cell arteritis=polymyalgia rheumatica. J Rheumatol 26:2698–2700. Stevens RJ, Hughes RA. (1995). The aetiopathogenesis of giant cell arteritis. Br J Rheumatol 34:960. Straud R, Corman LC. (1996). Association of parvovirus B19 infection with giant cell arteritis. Clin Infect Dis 22:1123.
Page 2 and 3:
This page intentionally left blank
Page 4 and 5:
Page 6 and 7:
Thieme New York 333 Seventh Avenue
Page 8 and 9:
To our wives, Hilary and Liz and to
Page 10 and 11:
Page 12 and 13:
x Preface We would again like to th
Page 14 and 15:
2 Clinical Pathways in Neuro-Ophtha
Page 16 and 17:
Page 18 and 19:
Page 20 and 21:
Page 22 and 23:
10 Clinical Pathways in Neuro-Ophth
Page 24 and 25:
Page 26 and 27:
Page 28 and 29:
Page 30 and 31:
Table 1-12. Clinical Features of Ra
Page 32 and 33:
Page 34 and 35:
Page 36 and 37:
Page 38 and 39:
Page 40 and 41:
Page 42 and 43:
Page 44 and 45:
Page 46 and 47:
Page 48 and 49:
Page 50 and 51:
Page 52 and 53:
Page 54 and 55:
Page 56 and 57:
Page 58 and 59:
Page 60 and 61:
Page 62 and 63:
Page 64 and 65:
Page 66 and 67:
Page 68 and 69:
Page 70 and 71:
Page 72 and 73:
Page 74 and 75:
Page 76 and 77:
Page 78 and 79: 66 Clinical Pathways in Neuro-Ophth
Page 112 and 113: 100 Clinical Pathways in Neuro-Opht
Page 178 and 179:
Page 180 and 181:
168 Clinical Pathways in Neuro-Opht
Page 182 and 183:
Page 184 and 185:
Page 186 and 187:
Page 188 and 189:
Page 190 and 191:
Page 192 and 193:
Page 194 and 195:
Page 196 and 197:
Page 198 and 199:
Page 200 and 201:
Page 202 and 203:
Page 204 and 205:
Page 206 and 207:
Page 208 and 209:
Page 210 and 211:
Page 212 and 213:
Page 214 and 215:
Page 216 and 217:
Page 218 and 219:
Page 220 and 221:
Page 222 and 223:
Page 224 and 225:
Page 226 and 227:
Page 228 and 229:
Page 230 and 231:
Page 232 and 233:
Page 234 and 235:
Page 236 and 237:
Page 238 and 239:
Page 240 and 241:
Page 242 and 243:
Page 244 and 245:
Page 246 and 247:
Page 248 and 249:
Page 250 and 251:
Page 252 and 253:
Page 254 and 255:
Page 256 and 257:
Page 258 and 259:
Page 260 and 261:
Page 262 and 263:
Page 264 and 265:
Page 266 and 267:
Page 268 and 269:
Page 270 and 271:
Page 272 and 273:
Page 274 and 275:
Page 276 and 277:
Page 278 and 279:
Page 280 and 281:
Page 282 and 283:
Page 284 and 285:
Page 286 and 287:
Page 288 and 289:
Page 290 and 291:
Page 292 and 293:
Page 294 and 295:
Page 296 and 297:
Page 298 and 299:
Page 300 and 301:
Page 302 and 303:
Page 304 and 305:
Page 306 and 307:
Page 308 and 309:
13 r Sixth Nerve Palsies What is th
Page 310 and 311:
Page 312 and 313:
Page 314 and 315:
Page 316 and 317:
Page 318 and 319:
Page 320 and 321:
Page 322 and 323:
Page 324 and 325:
Page 326 and 327:
Page 328 and 329:
Page 330 and 331:
Page 332 and 333:
Page 334 and 335:
Page 336 and 337:
Page 338 and 339:
Page 340 and 341:
Page 342 and 343:
Page 344 and 345:
Page 346 and 347:
Page 348 and 349:
Page 350 and 351:
Page 352 and 353:
Page 354 and 355:
Page 356 and 357:
Page 358 and 359:
Page 360 and 361:
Page 362 and 363:
Page 364 and 365:
Page 366 and 367:
Page 368 and 369:
Page 370 and 371:
Page 372 and 373:
Page 374 and 375:
Page 376 and 377:
Page 378 and 379:
Page 380 and 381:
Page 382 and 383:
Page 384 and 385:
Page 386 and 387:
Page 388 and 389:
Page 390 and 391:
Page 392 and 393:
Page 394 and 395:
Page 396 and 397:
Page 398 and 399:
Page 400 and 401:
Page 402 and 403:
Page 404 and 405:
Page 406 and 407:
Page 408 and 409:
Page 410 and 411:
Page 412 and 413:
Page 414 and 415:
Page 416 and 417:
Page 418 and 419:
Page 420 and 421:
Page 422 and 423:
Page 424 and 425:
Page 426 and 427:
Page 428 and 429:
Page 430 and 431:
Page 432 and 433:
Page 434 and 435:
Page 436 and 437:
Page 438 and 439:
Page 440 and 441:
Page 442 and 443:
Page 444 and 445:
Page 446 and 447:
Page 448 and 449:
Page 450 and 451:
Page 452 and 453:
Page 454 and 455:
Page 456 and 457:
Page 458 and 459:
Page 460 and 461:
Page 462 and 463:
Page 464 and 465:
Page 466 and 467:
Page 468 and 469:
Page 470 and 471:
Page 472 and 473:
Page 474 and 475:
Page 476 and 477:
Index r Page numbers in italic indi
Page 478 and 479:
Page 480 and 481:
Page 482 and 483:
Page 484 and 485:
Page 486 and 487:
Page 488 and 489:
Page 490 and 491:
Page 492 and 493:
Page 494 and 495:
Page 496 and 497:
Page 498:
show all

Clinical Pathways in Neuro-ophthalmology : An ... - E-Lib FK UWKS

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?